Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement.
In light of the ongoing advancements in the treatment of patients with early- and locally advanced-stage non-small cell lung cancer (NSCLC), the members of the Spanish Lung Cancer Group (GECP) deemed it necessary to update its 2023 consensus suggestions for the management of these patients.
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Institut d'Investigació i Innovació Parc Taulí (I3PT) |
| Repositorio: | r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí |
| OAI Identifier: | oai:i3pt.fundanetsuite.com:p6845 |
| Acceso en línea: | https://i3pt.portalinvestigacion.com/publicaciones/6845 https://www.scopus.com/inward/record.uri?eid=2-s2.0-105017875166&doi=10.21037%2Ftlcr-2025-619&partnerID=40&md5=e9bd17c12fbd35994e4af1705f51ac51 |
| Access Level: | acceso abierto |
| Palabra clave: | Early, expert consensus, locally advanced, non-small cell lung cancer (NSCLC), treatment |
| Sumario: | In light of the ongoing advancements in the treatment of patients with early- and locally advanced-stage non-small cell lung cancer (NSCLC), the members of the Spanish Lung Cancer Group (GECP) deemed it necessary to update its 2023 consensus suggestions for the management of these patients. |
|---|